SEC Comment Letter for AC Immune SA (ACIU) (CIK 0001651625) (ACIU) — Feb 25, 2020
AC Immune SA (ACIU) (CIK 0001651625)
Date: Feb. 25, 2020 · CIK: 0001651625 · Accession: 0000000000-20-001675
AI Filing Summary & Sentiment
File numbers found in text: 001-37891
Letter
February 24, 2020 Joerg Hornstein Chief Financial Officer AC Immune SA EPFL Innovation Park Building B 1015 Lausanne Switzerland Re:AC Immune SA Form 20-F for the Fiscal Year Ended December 31, 2018 Filed April 19, 2019 File No. 001-37891 Dear Mr. Hornstein: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
February 24, 2020
Joerg Hornstein
Chief Financial Officer
AC Immune SA
EPFL Innovation Park
Building B
1015 Lausanne
Switzerland
Re:AC Immune SA
Form 20-F for the Fiscal Year Ended December 31, 2018
Filed April 19, 2019
File No. 001-37891
Dear Mr. Hornstein:
We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences